Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
What Credit Card Has The Best Rewards Program
Explore the credit cards with the best rewards programs to maximize your benefits and savings. Find your perfect match.
26,855 articles
Congressman Issues Dire Social Security Warning Now
A high-profile congressman warns that Social Security could face cuts as the trust fund nears insolvency in the early...
Elizabeth Warren Seeks Information on Meta’s Stablecoin Plans
Sen. Elizabeth Warren has sent a formal request to Mark Zuckerberg, seeking details on Meta’s latest stablecoin pilot...
Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Billionaire Bill Gates' Foundation Recasts Portfolio Mix
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
Cisco Rolls AI Agents Across 90,000 Employees in AI Push
Cisco is deploying personalized AI agents to its 90,000 employees this fiscal year, promising faster decisions and sm...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Boyd Gaming 17.2% Upside Sparks Buy Action Before July 23
As Boyd Gaming nears its July 23 earnings, traders are weighing a potential 17.2% upside fueled by a disciplined buyb...
Stocks That Will Profit From Silicon Valley Defense Surge
Silicon Valley is fueling a defense tech surge, reshaping the investment landscape. This piece identifies five stocks...
Netflix Stock Hits 52-Week Low as Earnings Dismay Deepens
Netflix reported a mixed Q2 showing revenue growth but softer margins, sending shares to new 52-week lows. Analysts s...
Revolution Medicines This Year: Bulls and Bears for RVMD
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status